# Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy

> **NCT02551003** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Children's Hospital of Fudan University**

## Conditions studied

- Hypoxic Ischemic Encephalopathy
- Cerebral Infarction

## Interventions

- **DRUG:** Autologous cord blood
- **DEVICE:** Hypothermia

## Key facts

- **NCT ID:** NCT02551003
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09-08
- **Primary completion:** 2016-12-30
- **Final completion:** 2016-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study did not commence due to unforeseen challenges in securing adequate funding and resources, coupled with logistical constraints.
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551003, "Neuroprotective Effect of Autologous Cord Blood Combined With Therapeutic Hypothermia Following Neonatal Encephalopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02551003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*